ECMO remains a potential option in life-threatening rheumatologic disease complications. In this review, 416 patients recovered due to ECMO who likely would not have otherwise survived. However, available evidence is largely limited to case reports and small retrospective studies. Limitations include small sample sizes and heterogeneity in reported data.
Falaas et al. (Mon,) studied this question.